Shanghai Kehua Bio-engineering Co (SZSE:002022) LT-Debt-to-Total-Asset : 0.12 (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shanghai Kehua Bio-engineering Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.12.

Shanghai Kehua Bio-engineering Co's long-term debt to total assets ratio increased from Mar. 2023 (0.10) to Mar. 2024 (0.12). It may suggest that Shanghai Kehua Bio-engineering Co is progressively becoming more dependent on debt to grow their business.

Shanghai Kehua Bio-engineering Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Shanghai Kehua Bio-engineering Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kehua Bio-engineering Co LT-Debt-to-Total-Asset Chart

Shanghai Kehua Bio-engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.08

0.13

0.11

0.09

0.12

Shanghai Kehua Bio-engineering Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.10	0.11	0.11	0.12	0.12

Shanghai Kehua Bio-engineering Co LT-Debt-to-Total-Asset Calculation

Shanghai Kehua Bio-engineering Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	801.957	/	6807.74
	=	0.12

Shanghai Kehua Bio-engineering Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	801.418	/	6620.133
	=	0.12

Shanghai Kehua Bio-engineering Co (SZSE:002022) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Shanghai Kehua Bio-engineering Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Shanghai Kehua Bio-engineering Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Kehua Bio-engineering Co (SZSE:002022) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233

Website

http://www.skhb.com

Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.

Executives

Li Ming	Executives
He Jian Wen	Executives
Ji Yu Ming	Supervisors
Li Ji	Executives
Sha Li Wu	Director
Wang Man	Directors, executives
Tang Wei Guo	Director

Shanghai Kehua Bio-engineering Co (SZSE:002022) Headlines

No Headlines